The Powerful Companies Driving Local Drugstores Out of Business

Published On Oct 19, 2024, 5:00 AM

A New York Times article highlights how pharmacy benefit managers (P.B.M.s) are undermining independent drugstores across the U.S., leading to their closure and creating pharmacy deserts in many communities. P.B.M.s, hired by employers and government programs to manage prescription drug benefits, are reportedly underpaying small pharmacies, making it difficult for them to survive. This pattern enables large P.B.M.s that have their own competing pharmacies to gain more customers after these local drugstores shut down, thus consolidating their market power at the expense of patient access and community health.

Stock Forecasts

The ongoing consolidation and market power of large P.B.M.s could lead to increased scrutiny and regulatory challenges in the future. Investors should be wary of P.B.M.s and their parent companies as potential targets for regulatory reforms, which could negatively impact their profitability.

As the closure of independent pharmacies continues, larger pharmacy chains may benefit from acquiring their customers. This could lead to higher sales for those pharmacy chains in the short term, potentially driving their stock prices up.

Related News

Shares of the health care conglomerate dropped after the sudden departure of Karen Lynch and a downbeat update on the state of the company’s finances.

CVS Health tapped industry veteran David Joyner to become CEO and turnaround the struggling business.

Shares fell 11% in premarket trading, adding to this year's losses, as CVS also forecast quarterly adjusted profit below estimates. Shareholders have become increasingly nervous about repeated profit forecast cuts this year as its drugstores face reimbursement pressures and high costs hit the health insurance industry. Investor Glenview Capital said earlier this month it was working with CVS to help improve operations as the company faces one of the most challenging periods in its six-decade history.